Engineered Ginseng‐Derived Nanovesicles with MCSP Targeting and Mitochondria‐Directed Prodrug Delivery for Synergistic Immunotherapy of Metastatic Melanoma
Year: 2025
Type: article
Language: en
Topic: Natural Compounds in Disease Treatment
Authors and affiliations:
raw_author_name: Aixue Li
raw_affiliation_strings: Department of Oncology, Shanghai Medical College Fudan University  Shanghai 200032 China
Department of Pharmacy Fudan University Shanghai Cancer Center  Shanghai 200032 China
School of Pharmacy Shandong University of Traditional Chinese Medicine  Jinan 250355 China
State Key Laboratory of Neurology and Oncology Drug Development  Nanjing 210000 China
raw_author_name: Yongwei Gu
raw_affiliation_strings: Department of Oncology, Shanghai Medical College Fudan University  Shanghai 200032 China
Department of Pharmacy Fudan University Shanghai Cancer Center  Shanghai 200032 China
State Key Laboratory of Neurology and Oncology Drug Development  Nanjing 210000 China
raw_author_name: Mengyuan He
raw_affiliation_strings: School of Pharmacy Shandong University of Traditional Chinese Medicine  Jinan 250355 China
raw_author_name: Yuanye Zeng
raw_affiliation_strings: Department of Oncology, Shanghai Medical College Fudan University  Shanghai 200032 China
Department of Pharmacy Fudan University Shanghai Cancer Center  Shanghai 200032 China
State Key Laboratory of Neurology and Oncology Drug Development  Nanjing 210000 China
raw_author_name: Xuejun Wang
raw_affiliation_strings: Department of Oncology, Shanghai Medical College Fudan University  Shanghai 200032 China
Department of Pharmacy Fudan University Shanghai Cancer Center  Shanghai 200032 China
State Key Laboratory of Neurology and Oncology Drug Development  Nanjing 210000 China
raw_author_name: Xiaomeng Tang
raw_affiliation_strings: Department of Oncology, Shanghai Medical College Fudan University  Shanghai 200032 China
Department of Pharmacy Fudan University Shanghai Cancer Center  Shanghai 200032 China
raw_author_name: Rongchen Mao
raw_affiliation_strings: Department of Oncology, Shanghai Medical College Fudan University  Shanghai 200032 China
Department of Pharmacy Fudan University Shanghai Cancer Center  Shanghai 200032 China
raw_author_name: Fengna Li
raw_affiliation_strings: School of Pharmacy, Faculty of Medicine Macau University of Science and Technology  Macau SAR China
raw_author_name: Qingqing Chai
raw_affiliation_strings: Department of Oncology, Shanghai Medical College Fudan University  Shanghai 200032 China
Department of Pharmacy Fudan University Shanghai Cancer Center  Shanghai 200032 China
raw_author_name: Kang Fang
raw_affiliation_strings: School of Pharmacy Shandong University of Traditional Chinese Medicine  Jinan 250355 China
raw_author_name: Zhiqin Fu
raw_affiliation_strings: School of Pharmacy, Faculty of Medicine Macau University of Science and Technology  Macau SAR China
Shanghai Wei Er Lab  Shanghai 201707 China
raw_author_name: Dan Li
raw_affiliation_strings: Department of Oncology, Shanghai Medical College Fudan University  Shanghai 200032 China
Department of Pharmacy Fudan University Shanghai Cancer Center  Shanghai 200032 China
State Key Laboratory of Neurology and Oncology Drug Development  Nanjing 210000 China
raw_author_name: Xin Wu
raw_affiliation_strings: School of Pharmacy Shandong University of Traditional Chinese Medicine  Jinan 250355 China
Shanghai Wei Er Lab  Shanghai 201707 China
raw_author_name: Jiyong Liu
raw_affiliation_strings: Department of Oncology, Shanghai Medical College Fudan University  Shanghai 200032 China
Department of Pharmacy Fudan University Shanghai Cancer Center  Shanghai 200032 China
School of Pharmacy Shandong University of Traditional Chinese Medicine  Jinan 250355 China
School of Pharmacy, Faculty of Medicine Macau University of Science and Technology  Macau SAR China
State Key Laboratory of Neurology and Oncology Drug Development  Nanjing 210000 China